Cargando…

Application of MultiStem(®) Allogeneic Cells for Immunomodulatory Therapy: Clinical Progress and Pre-Clinical Challenges in Prophylaxis for Graft Versus Host Disease

The last decade has seen much progress in adjunctive cell therapy for immune disorders. Both corporate and institutional Phase III studies have been run using mesenchymal stromal cells (MSC) for treatment of Graft versus Host Disease (GvHD), and product approval has been achieved for treatment of pe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vaes, Bart, Van’t Hof, Wouter, Deans, Robert, Pinxteren, Jef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2012
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506828/ https://www.ncbi.nlm.nih.gov/pubmed/23205020 http://dx.doi.org/10.3389/fimmu.2012.00345

Ejemplares similares

A general theory of multistem drift tube structures proposed for proton linacs
por: Dôme, Georges, et al.
Publicado: (1967)

Neuroinflammatory signals enhance the immunomodulatory and neuroprotective properties of multipotent adult progenitor cells
por: Ravanidis, Stylianos, et al.
Publicado: (2015)

Human multipotent adult progenitor cells effectively reduce graft‐vs‐host disease while preserving graft‐vs‐leukemia activity
por: Metheny, Leland, et al.
Publicado: (2021)

Immunomodulatory Effects of Histone Deacetylation Inhibitors in Graft-vs.-Host Disease After Allogeneic Stem Cell Transplantation
por: Xu, Xiaoxiao, et al.
Publicado: (2021)

Clinical Outcomes Using Mycophenolate and Tacrolimus for Graft-versus-Host Disease Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplant: A Single Institution Experience
por: Hashmi, Hamza, et al.
Publicado: (2020)

P1308: RUXOLITINIB AS GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN APLASTIC ANEMIA PATIENTS
por: Zhang, Xiaoyu, et al.
Publicado: (2023)

Immunomodulatory Therapies for the Treatment of Graft-versus-host Disease
por: Braun, Lukas M., et al.
Publicado: (2021)

IFN‐γ and PPARδ influence the efficacy and retention of multipotent adult progenitor cells in graft vs host disease
por: Carty, Fiona, et al.
Publicado: (2021)

The development of graft-versus-host disease prophylaxis
por: Cutler, Corey
Publicado: (2023)

Why Do HIV Pre-Exposure Prophylaxis Users Discontinue Pre-Exposure Prophylaxis Care? A Mixed Methods Survey in a Pre-Exposure Prophylaxis Clinic in Belgium
por: Vanbaelen, Thibaut, et al.
Publicado: (2022)

Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis
por: Hamadani, Mehdi, et al.
Publicado: (2020)

A Short History of Skin Grafting in Burns: From the Gold Standard of Autologous Skin Grafting to the Possibilities of Allogeneic Skin Grafting with Immunomodulatory Approaches
por: Schlottmann, Frederik, et al.
Publicado: (2021)

Graft-versus-host disease in allogeneic transplantation: the good and the bad
por: Kröger, Nicolaus-Martin
Publicado: (2022)

Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia
por: Lazzari, Lorenzo, et al.
Publicado: (2022)

Clinical and economic burden associated with graft-versus-host disease following allogeneic hematopoietic cell transplantation in France
por: Michonneau, David, et al.
Publicado: (2023)

Evaluation of risk for graft-versus-host disease in children who receive less than the full doses of mini-dose methotrexate for graft-versus-host disease prophylaxis in allogeneic hematopoietic stem cell transplantation
por: Yum, Sook Kyung, et al.
Publicado: (2013)

Novel pre-clinical mouse models for chronic Graft-versus-Host Disease
por: Verlaat, Lydia, et al.
Publicado: (2023)

A Limited Sampling Strategy for Therapeutic Drug Monitoring of Mycophenolate Mofetil for Prophylaxis of Acute Graft-Versus-Host Disease in Allogeneic Stem Cell Transplantation
por: Gota, Vikram, et al.
Publicado: (2020)

Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease
por: van Lier, Yannouck F., et al.
Publicado: (2023)

A61 PRE-ALLOGENIC STEM CELL TRANSPLANT CLINICAL FACTORS AND THEIR ASSOCIATION WITH CHRONIC GRAFT VERSUS HOST DISEASE - A RISK FACTOR ANALYSIS FOR CHRONIC GVHD PREDICTION
por: Alajmi, A, et al.
Publicado: (2022)

Transgender Women in Clinical Trials of Pre-Exposure Prophylaxis
por: Grant, Robert M., et al.
Publicado: (2016)

The Role of Micronutrients in Graft-VS.-Host Disease: Immunomodulatory Effects of Vitamins A and D
por: Chen, Xiao, et al.
Publicado: (2018)

THE FACTOR OF IMMUNIZATION IN THE RAT : THE EFFECT OF ALLOGENEIC IMMUNIZATION ON GRAFT-VERSUS-HOST ACTIVITY
por: Ford, William L., et al.
Publicado: (1971)

Letermovir for Prophylaxis and Pre-emptive Therapy of Cytomegalovirus Infection in Paediatric Allogeneic Haematopoietic Cell Transplant Patients
por: Körholz, Katharina F., et al.
Publicado: (2022)

Randomised, double-blind, placebo-controlled trial of oral budesonide for prophylaxis of acute intestinal graft-versus-host disease after allogeneic stem cell transplantation (PROGAST)
por: Schmelz, Renate, et al.
Publicado: (2014)

Comparison of Subcutaneous versus Intravenous Alemtuzumab for Graft-versus-Host Disease Prophylaxis with Fludarabine/Melphalan–Based Conditioning in Matched Unrelated Donor Allogeneic Stem Cell Transplantation
por: Patel, Khilna, et al.
Publicado: (2016)

Impact of anti-thymocyte globulin dose for graft-versus-host disease prophylaxis in allogeneic hematopoietic cell transplantation from matched unrelated donors: a multicenter experience
por: Butera, Sara, et al.
Publicado: (2021)

Gastric and small bowel perforations secondary to mucormycosis and graft versus host disease in an allogeneic transplant host
por: Ibrahim, Uroosa, et al.
Publicado: (2021)

Crosstalk with Inflammatory Macrophages Shapes the Regulatory Properties of Multipotent Adult Progenitor Cells
por: Ravanidis, Stylianos, et al.
Publicado: (2017)

Pre-exposure Prophylaxis: The Delivery Challenge
por: Venter, Willem D. F.
Publicado: (2018)

Pericardial effusion and cardiac tamponade: clinical manifestation of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
por: Ferreira, David Cavalcanti, et al.
Publicado: (2014)

Cell-based therapy in prophylaxis and treatment of chronic graft-versus-host disease
por: Doglio, Matteo, et al.
Publicado: (2022)

Immunomodulatory Activity of Human Bone Marrow and Adipose-Derived Mesenchymal Stem Cells Prolongs Allogenic Skin Graft Survival in Nonhuman Primates
por: Sotoodehnejadnematalahi, Fattah, et al.
Publicado: (2021)

Mesenchymal stem cells provide prophylaxis against acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: A meta-analysis of animal models
por: Wang, Li, et al.
Publicado: (2016)

Comparison of immune reconstitution between anti-T-lymphocyte globulin and posttransplant cyclophosphamide as acute graft-versus-host disease prophylaxis in allogeneic myeloablative peripheral blood stem cell transplantation
por: Massoud, Radwan, et al.
Publicado: (2021)

Acute Graft-Versus-Host Disease of the Kidney in Allogeneic Rat Bone Marrow Transplantation
por: Higo, Seiichiro, et al.
Publicado: (2014)

Interleukin-22 in Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation
por: Lamarthée, Baptiste, et al.
Publicado: (2016)

Purinergic Signalling in Allogeneic Haematopoietic Stem Cell Transplantation and Graft-versus-Host Disease
por: Cuthbertson, Peter, et al.
Publicado: (2021)

THE ALLOGENEIC EFFECT IN INBRED MICE : IV. REGULATORY INFLUENCES OF GRAFT-VS.-HOST REACTIONS ON HOST T LYMPHOCYTE FUNCTIONS
por: Osborne, David P., et al.
Publicado: (1973)

Pre-clinical evaluation of antiproteases as potential candidates for HIV-1 pre-exposure prophylaxis
por: Herrera, Carolina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k17sou7ntvu21ajadgorqpuht8